continuous molecular monitoring
Extensive clinical validation and deployment are what remain to make it routine, according to University of New South Wales Scientia Professor Justin Gooding.
It is currently conducting clinical studies and expanding its teams in Australia and the US.
The CMM platform renders real-time, continuous molecular-level insights that help inform dosing decisions.